Amrecibart
Based on 1 publication(s) in Google Scholar
Amrecibart is an anti-coagulation factor 11 human IgG4 κ monoclonal antibody. Recommend Isotype Controls: Human IgG4 kappa, Isotype Control (HY-P99003).
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 95%
- CAS No.: 3008610-20-3
- 분자량:145.736 kDa
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Amrecibart
More
Biological Activity
제품 설명
Isotype
Human IgG4 kappa
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
Coagulation factor XI
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Gene ID
Accession
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
IgG4-kappa
신청
ELISA, FACS, Functional assay
Chemical Information
-
CAS No. 3008610-20-3
-
Appearance Liquid
-
분자량 145.736 kDa
-
Color Colorless to light yellow
-
SMILES
[Amrecibart]
-
Synonyms
REGN-9933
-
선적
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Blood
Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat). [Abstract]2026 Jun 11:blood.2025032276. PMID: 42275249
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)